Commit To Purchase Nektar Therapeutics At $8, Earn 7.9% Annualized Using Options
February 04, 2016 at 11:51 AM EST
Investors considering a purchase of Nektar Therapeutics (NKTR) shares, but tentative about paying the going market price of $11.76/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $8 strike, which has a bid at the time of this writing of 55 cents..